Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma.
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma. Gynecol Oncol. 2017 07; 146(1):11-15.
View in:
PubMed
subject areas
Clinical Trials as Topic
Disease-Free Survival
Female
Humans
Ovarian Neoplasms
Poly(ADP-ribose) Polymerase Inhibitors
authors with profiles
Whitney S Graybill